The inquiry, led by attorney Juan Monteverde, focuses on the fairness of the transaction terms for current Sanara MedTech (NASDAQ: SMTI) stockholders. Monteverde & Associates, a firm recognized in the 2025 ISS Securities Class Action Services Report, is currently inviting shareholders to review the acquisition details for potential legal concerns.
Investors who hold common stock in Sanara MedTech are encouraged to reach out to the firm for a free consultation regarding their rights in this merger. Those seeking additional information can contact Juan Monteverde via email at jmonteverde@monteverdelaw.com or by calling (212) 971-1341. The firm, operating out of the Empire State Building, specializes in securities litigation and maintains a track record of handling cases through trial and appellate courts.
Comments (0)
No comments yet. Be the first!